Why Publish with The Journal of Clinical Endocrinology & Metabolism?

Global readership and article-level impact 

JCEM is read by researchers around the world, ensuring global reach and impact. In 2022, articles from the journal were downloaded over 8,000,000 times.

Our authors, editors, and readers combined come from more than 200 countries and territories. The Endocrine Society journals are included in major indexing services for discovery and citation. 

Authors can view all article-level metrics on the OUP platform.

High-quality peer review

JCEM has an internationally recognized Editorial Board. The journal’s editorial leaders have been selected for their expertise across a range of topics relevant to endocrinology, ensuring your manuscript receives consideration by thought leaders in the field.

Journal metrics

• 2023 Impact Factor: 5.0.
  (Source: Journal Citation Reports™ from Clarivate, 2024.)

• 2023 CiteScore: 11.4.

• 2023 average Altmetric attention score*: 22.83.
  Altmetric attention scores indicate how much attention articles are receiving online via various channels, including news outlets, social media, and policy documents. Find out more here.
  (*of papers published in 2023).

Our publishing partner, Oxford University Press (OUP), is a signatory of the San Francisco Declaration on Research Assessment (DORA), which is a world-wide initiative designed to improve the ways in which the outputs of scholarly research are evaluated. This includes reporting on a broader range of metrics. Find out more from OUP about the available metrics to assess both journals and individual articles here.

Contribute to the global advancement of knowledge

JCEM provides a peer-reviewed forum for the dissemination of novel insights and innovations across key disciplines within and related to endocrinology.

Open Access Options

JCEM offers the option of publishing under either a standard license or an open access license.

Accessible for readers in developing countries

To ensure that non-profit research institutions in developing nations have access to critical research, the Endocrine Society’s publishing partner, Oxford University Press (OUP), participates in a number of free or heavily-reduced rate access initiatives for developing countries. These include EIFL, Research4Life, and the Oxford Developing Countries Program. Find out more here.

Published by the Endocrine Society in partnership with OUP

The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions. The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries.

Our publishing partner - Oxford University Press (OUP) - is the world’s largest university press, meaning they serve the academic community as no other publisher can. OUP works in partnership with institutions and learned societies to further knowledge and research worldwide. Find out more about OUP’s academic publishing here.